Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Angelica Dahurica extract helps reduce hair loss and improve hair growth and scalp condition.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Stem cell therapy may help treat tough hair loss cases.

Color changes in Minoxidil hair products do not affect their effectiveness.

Hordenine may help hair grow by activating a specific cell growth pathway.

The inhibitor DPP can promote hair growth.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Androgenetic alopecia in women needs more research and better management strategies.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Dermoscopy helps diagnose different scalp conditions by showing unique signs for each disorder.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Bicalutamide may help treat female pattern hair loss.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Aging reduces skin stem cell function, leading to changes like hair loss and slower wound healing.